Search filters

List of works by Kerry D Fisher

"Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours.

scientific article published on 6 November 2014

A PTENtial cause for the selectivity of oncolytic viruses?

scientific article published in February 2016

Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth

scientific article published on 28 December 2015

Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood.

scientific article published on 20 February 2014

Adenovirus type 5 interactions with human blood cells may compromise systemic delivery.

scientific article published on 31 March 2006

Adenovirus: teaching an old dog new tricks

scientific article published on 01 September 2011

Cancer gene therapy with targeted adenoviruses

article

Coating of adeno-associated virus with reactive polymers can ablate virus tropism, enable retargeting and provide resistance to neutralising antisera

scientific article published in April 2008

Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood components.

scientific article

Combining Oncolytic Adenovirus with Radiation-A Paradigm for the Future of Radiosensitization.

scientific article

Development of a Positive-readout Mouse Model of siRNA Pharmacodynamics.

scientific article

E-selectin is a viable route of infection for polymer-coated adenovirus retargeting in TNF-α-activated human umbilical vein endothelial cells

scientific article published on 10 February 2011

Enhanced gene transfer activity of peptide-targeted gene-delivery vectors

scientific article

Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells.

scientific article

External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase

scientific article published on 26 March 2020

Glycoviruses: chemical glycosylation retargets adenoviral gene transfer

article

Group B adenovirus enadenotucirev infects polarised colorectal cancer cells efficiently from the basolateral surface expected to be encountered during intravenous delivery to treat disseminated cancer.

scientific article published on 2 March 2017

HPMA copolymers for masking and retargeting of therapeutic viruses.

scientific article published on 29 December 2009

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1.

scientific article published on 08 January 2009

Improved in vitro human tumor models for cancer gene therapy

scientific article published on 20 April 2015

In vitro evaluation of a 'stealth' adenoviral vector for targeted gene delivery to adult mammalian neurones.

scientific article published in April 2009

Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes.

scientific article

Macrophages and their interactions with oncolytic viruses.

scientific article published on 08 July 2015

Making Oncolytic Virotherapy a Clinical Reality: The European Contribution

scientific article published on 10 August 2017

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators.

scientific article

Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies

scientific article published on 20 June 2017

Oncolytic viruses: finally delivering

scientific article

OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution

scientific article published on 14 December 2016

Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy

scientific article published in August 2007

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection.

scientific article published on 19 September 2017

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.

scientific article published in March 2001

Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus

scientific article

Quantification of siRNA using competitive qPCR.

scientific article

Recombinant viral vaccines for cancer ⬇️

scientific article published on August 21, 2012

Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer

scientific article published in March 2008

Solid Tumor Immunotherapy with T Cell Engager-Armed Oncolytic Viruses

scientific article published on 13 September 2017

Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins ⬇️

scientific article published on October 18, 2010

Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer

scientific article published on 18 June 2012

Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathway ⬇️

scientific article published on August 22, 2011

Under Pressure: Elevated Blood Pressure Enhances Targeting of Tumors by Oncolytic Viruses.

scientific article published on February 2016

Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.

scientific article published on 11 December 2007

Paulina is supported by:

About Paulina

Help